FDA rules out bisphosphonate, thigh fracture link (Reuters)

by admin on March 10, 2010

Reuters – U.S. regulators said on Wednesday they have found no link between oral bisphosphonate osteoporosis medications such as Merck & Co Inc’s Fosamax and certain thigh bone fractures.

Leave a Comment

Previous post:

Next post: